Sandoz Group AG (FRA:D8Y0) PB Ratio : 1.76 (As of May. 24, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-24), Sandoz Group AG's share price is €32.40. Sandoz Group AG's Book Value per Share for the quarter that ended in Dec. 2023 was €18.44. Hence, Sandoz Group AG's PB Ratio of today is 1.76.

The historical rank and industry rank for Sandoz Group AG's PB Ratio or its related term are showing as below:

FRA:D8Y0' s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 1.87
Current: 1.83

During the past 2 years, Sandoz Group AG's highest PB Ratio was 1.87. The lowest was 0.00. And the median was 0.00.

FRA:D8Y0's PB Ratio is ranked better than
52.94% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.99 vs FRA:D8Y0: 1.83

During the past 12 months, Sandoz Group AG's average Book Value Per Share Growth Rate was -8.00% per year.

Back to Basics: PB Ratio

Sandoz Group AG PB Ratio Historical Data

The historical data trend for Sandoz Group AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG PB Ratio Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

PB Ratio

1.54

Sandoz Group AG Quarterly Data
	Dec22	Dec23
PB Ratio	-	1.54

Competitive Comparison of Sandoz Group AG's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's PB Ratio falls into.

Sandoz Group AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Sandoz Group AG's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	32.40	/	18.439
	=	1.76

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Sandoz Group AG (FRA:D8Y0) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Sandoz Group AG PB Ratio Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (FRA:D8Y0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (FRA:D8Y0) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZNY:USA SDZz:UK SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (FRA:D8Y0) Headlines

No Headlines